Afatinib vs Loncastuximab Tesirine

## Afatinib vs Loncastuximab Tesirine: Overview

This comparison examines the pharmacological differences between **Afatinib** and **Loncastuximab Tesirine**.

## Mechanism of Action

**Afatinib**: Irreversible covalent inhibitor of ErbB family (EGFR/HER1, HER2, HER4) tyrosine kinases.

## Pharmacokinetics

**Half-life**: Afatinib — 37 hours; Loncastuximab Tesirine — N/A.

## Chemical Properties

**Molecular Formula**: Afatinib — C24H25ClFN5O3; Loncastuximab Tesirine — N/A.

**Molecular Weight**: Afatinib — 485.9400 g/mol; Loncastuximab Tesirine — N/A.

**Type**: Afatinib — Small molecule; Loncastuximab Tesirine — Antibody drug conjugate.